Cargando…

Customization of a Model For Knowledge-Based Planning to Achieve Ideal Dose Distributions in Volume Modulated arc Therapy for Pancreatic Cancers

PURPOSE: To evaluate customizing a knowledge-based planning (KBP) model using dosimetric analysis for volumetric modulated arc therapy for pancreatic cancer. MATERIALS AND METHODS: The first model (M1) using 56 plans and the second model (M2) using 31 plans were created in the first 7 months of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitta, Yuya, Ueda, Yoshihiro, Isono, Masaru, Ohira, Shingo, Masaoka, Akira, Karino, Tsukasa, Inui, Shoki, Miyazaki, Masayoshi, Teshima, Teruki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415244/
https://www.ncbi.nlm.nih.gov/pubmed/34566285
http://dx.doi.org/10.4103/jmp.JMP_76_20
_version_ 1783747929153994752
author Nitta, Yuya
Ueda, Yoshihiro
Isono, Masaru
Ohira, Shingo
Masaoka, Akira
Karino, Tsukasa
Inui, Shoki
Miyazaki, Masayoshi
Teshima, Teruki
author_facet Nitta, Yuya
Ueda, Yoshihiro
Isono, Masaru
Ohira, Shingo
Masaoka, Akira
Karino, Tsukasa
Inui, Shoki
Miyazaki, Masayoshi
Teshima, Teruki
author_sort Nitta, Yuya
collection PubMed
description PURPOSE: To evaluate customizing a knowledge-based planning (KBP) model using dosimetric analysis for volumetric modulated arc therapy for pancreatic cancer. MATERIALS AND METHODS: The first model (M1) using 56 plans and the second model (M2) using 31 plans were created in the first 7 months of the study. The ratios of volume of both kidneys overlapping the expanded planning target volume to the total volume of both kidneys (V(overlap)/V(whole)) were calculated in all cases to customize M1. Regression lines were derived from V(overlap)/V(whole) and mean dose to both kidneys. The third model (M3) was created using 30 plans which data put them below the regression line. For validation, KBP was performed with the three models on 21 patients. RESULTS: V(18) of the left kidney for M1 plans was 7.3% greater than for clinical plans. Dmean of the left kidney for M2 plans was 2.2% greater than for clinical plans. There was no significant difference between all kidney doses in M3 and clinical plans. Dmean of the left kidney for M2 plans was 2.2% greater than for clinical plans. Dmean to both kidneys did not differ significantly between the three models in validation plans with V(overlap)/V(whole) lower than average. In plans with larger than average volumes, the Dmean of validation plans created by M3 was significantly lower for both kidneys by 1.7 and 0.9 Gy than with M1 and M2, respectively. CONCLUSIONS: Selecting plans to register in a model by analyzing dosimetry and geometry is an effective means of improving the KBP model.
format Online
Article
Text
id pubmed-8415244
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-84152442021-09-24 Customization of a Model For Knowledge-Based Planning to Achieve Ideal Dose Distributions in Volume Modulated arc Therapy for Pancreatic Cancers Nitta, Yuya Ueda, Yoshihiro Isono, Masaru Ohira, Shingo Masaoka, Akira Karino, Tsukasa Inui, Shoki Miyazaki, Masayoshi Teshima, Teruki J Med Phys Original Article PURPOSE: To evaluate customizing a knowledge-based planning (KBP) model using dosimetric analysis for volumetric modulated arc therapy for pancreatic cancer. MATERIALS AND METHODS: The first model (M1) using 56 plans and the second model (M2) using 31 plans were created in the first 7 months of the study. The ratios of volume of both kidneys overlapping the expanded planning target volume to the total volume of both kidneys (V(overlap)/V(whole)) were calculated in all cases to customize M1. Regression lines were derived from V(overlap)/V(whole) and mean dose to both kidneys. The third model (M3) was created using 30 plans which data put them below the regression line. For validation, KBP was performed with the three models on 21 patients. RESULTS: V(18) of the left kidney for M1 plans was 7.3% greater than for clinical plans. Dmean of the left kidney for M2 plans was 2.2% greater than for clinical plans. There was no significant difference between all kidney doses in M3 and clinical plans. Dmean of the left kidney for M2 plans was 2.2% greater than for clinical plans. Dmean to both kidneys did not differ significantly between the three models in validation plans with V(overlap)/V(whole) lower than average. In plans with larger than average volumes, the Dmean of validation plans created by M3 was significantly lower for both kidneys by 1.7 and 0.9 Gy than with M1 and M2, respectively. CONCLUSIONS: Selecting plans to register in a model by analyzing dosimetry and geometry is an effective means of improving the KBP model. Wolters Kluwer - Medknow 2021 2021-08-07 /pmc/articles/PMC8415244/ /pubmed/34566285 http://dx.doi.org/10.4103/jmp.JMP_76_20 Text en Copyright: © 2021 Journal of Medical Physics https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Nitta, Yuya
Ueda, Yoshihiro
Isono, Masaru
Ohira, Shingo
Masaoka, Akira
Karino, Tsukasa
Inui, Shoki
Miyazaki, Masayoshi
Teshima, Teruki
Customization of a Model For Knowledge-Based Planning to Achieve Ideal Dose Distributions in Volume Modulated arc Therapy for Pancreatic Cancers
title Customization of a Model For Knowledge-Based Planning to Achieve Ideal Dose Distributions in Volume Modulated arc Therapy for Pancreatic Cancers
title_full Customization of a Model For Knowledge-Based Planning to Achieve Ideal Dose Distributions in Volume Modulated arc Therapy for Pancreatic Cancers
title_fullStr Customization of a Model For Knowledge-Based Planning to Achieve Ideal Dose Distributions in Volume Modulated arc Therapy for Pancreatic Cancers
title_full_unstemmed Customization of a Model For Knowledge-Based Planning to Achieve Ideal Dose Distributions in Volume Modulated arc Therapy for Pancreatic Cancers
title_short Customization of a Model For Knowledge-Based Planning to Achieve Ideal Dose Distributions in Volume Modulated arc Therapy for Pancreatic Cancers
title_sort customization of a model for knowledge-based planning to achieve ideal dose distributions in volume modulated arc therapy for pancreatic cancers
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415244/
https://www.ncbi.nlm.nih.gov/pubmed/34566285
http://dx.doi.org/10.4103/jmp.JMP_76_20
work_keys_str_mv AT nittayuya customizationofamodelforknowledgebasedplanningtoachieveidealdosedistributionsinvolumemodulatedarctherapyforpancreaticcancers
AT uedayoshihiro customizationofamodelforknowledgebasedplanningtoachieveidealdosedistributionsinvolumemodulatedarctherapyforpancreaticcancers
AT isonomasaru customizationofamodelforknowledgebasedplanningtoachieveidealdosedistributionsinvolumemodulatedarctherapyforpancreaticcancers
AT ohirashingo customizationofamodelforknowledgebasedplanningtoachieveidealdosedistributionsinvolumemodulatedarctherapyforpancreaticcancers
AT masaokaakira customizationofamodelforknowledgebasedplanningtoachieveidealdosedistributionsinvolumemodulatedarctherapyforpancreaticcancers
AT karinotsukasa customizationofamodelforknowledgebasedplanningtoachieveidealdosedistributionsinvolumemodulatedarctherapyforpancreaticcancers
AT inuishoki customizationofamodelforknowledgebasedplanningtoachieveidealdosedistributionsinvolumemodulatedarctherapyforpancreaticcancers
AT miyazakimasayoshi customizationofamodelforknowledgebasedplanningtoachieveidealdosedistributionsinvolumemodulatedarctherapyforpancreaticcancers
AT teshimateruki customizationofamodelforknowledgebasedplanningtoachieveidealdosedistributionsinvolumemodulatedarctherapyforpancreaticcancers